·CO-CEO of Asymchem Group

·MBA, Peking Univ.

·Over the past 20 years, Ms. Yang has coordinated the activities of more than ten subsidiaries of the Group and has made significant contributions guiding the company to become a leading global pharmaceutical outsourcing service enterprise

·MS, Peking Univ.

·18 years of industry experience at Novartis, served as clinical sciences therapeutic area head of ID and CV&M, and member of Disease Area Decision Board, Scientific Review Committee 

·Focus on early development and strategy

·20+ years of compliance experience in pharmaceutical industry

·Participated in the compilation of guidelines for NMPA, the Ministry of Industry and Information Technology etc.

·Rich experience in organization and implementation of EDC, CTMS, PV systems. 

• PhD, Sun Yat-sen University

• 12 years working experience at Hengrui Medicine

• Held senior roles in Clinical R&D, Monitoring and Early Clinical Operation

• Member of Anti-tumor Clinical Trial Committee Young Committee Member, Chinese Pharmacological Society

• Led the launch of multiple Class 1 new drugs in China

• Master, Peking University Health Science Center

• Former Senior Management at Novo Nordisk China

• 20 years clinical data management & statistical programming experience

• 10 years CRO industry experience, expert in team management, project control and quality compliance

• Graduate of Nankai University

• Former Branch President of a national joint-stock commercial bank

• Provided financial and consulting services for large enterprises, government platforms and listed biopharma companies

• Expert in corporate governance, system construction and talent development